For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It plays a role in over 200 medical conditions, including liver disease, cardiovascular disease,

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a small trial, researchers reported on Wednesday. The 48 participants in the nine-week trial all had moderately severe alcohol use disorder and were given either once-weekly Ozempic or a placebo.